OQS
COYA icon

Occudo Quantitative Strategies’s Coya Therapeutics COYA Stock Holding History

Occudo Quantitative Strategies’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100K Buy
23,642
+12,279
+108% +$57.4K 0.01% 711
2025
Q4 		$65.9K Buy
+11,363
New +$69.1K ﹤0.01% 659

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Occudo Quantitative Strategies's COYA Position: Q1 2026 in Review

Occudo Quantitative Strategies increased its Coya Therapeutics (COYA) stake by 108% in Q1 2026, buying an estimated $57.4K and bringing the position to 23,642 shares worth $100K. The position accounts for 0.01% of the portfolio, ranked #711.

Occudo Quantitative Strategies first reported a position in COYA in Q4 2025 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Occudo Quantitative Strategies held 23,642 shares of Coya Therapeutics worth $100K as of Q1 2026.
  • Occudo Quantitative Strategies bought 12,279 Coya Therapeutics shares in Q1 2026, an estimated $57.4K.
  • Coya Therapeutics made up 0.01% of Occudo Quantitative Strategies's portfolio in Q1 2026, its #711 holding.
  • Occudo Quantitative Strategies first reported a position in Coya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.